Following NM@PLGA‐MTI‐OXA treatment, increased infiltration of CD3+, CD4+, and CD8+ T cells into intestinal tumors was observed (Figure7A–D; Figures S23A–D and S24A–D, Supporting Information). Here, CD4 is linked to intestinal neoplasm.